Abstract
Background: Nox4 has been reported to promote tumor progression of various types of cancer through many different pathways. The current study was designed to evaluate the prognostic significance of Nox4 in patients with oral tongue squamous cell carcinoma (OTSCC) receiving surgical resection. Methods: We retrospectively analyzed the 161 patients with OTSCC treated with surgical resection, including 81 patients with high expression of Nox4 and 80 patients with low expression of Nox4. Two OTSCC cell lines, SAS and SCC4, were used to investigate the proliferation activity. Results: The univariate and multivariable analyses showed that negative nodal metastasis and low expression of Nox4 were significantly associated with superior disease-free survival (DFS) and overall survival (OS). Western blotting analysis indicated that Nox4 was highly expressed in these two OTSCC cell lines and knockdown of Nox4 was successful by transfecting with Nox4 shRNA. In addition, these cell lines were also treated with a Nox4 inhibitor (GKT-137831) and the results showed GKT-137831 could inhibit the proliferation of OTSCC tumor cells in a dose-dependent manner. Conclusion: Our study suggests that Nox4 plays an important role in disease progression of OTSCC and Nox4 overexpression is a poor prognostic factor for patients with OTSCC who received surgical resection.
Highlights
Head and neck squamous cell carcinoma (HNSCC) is one of the leading cancers worldwide and there are an estimated 500,000 new cases being diagnosed annually [1]
In order to explore the function of Nox4 in cancer ell metabolism of oral tongue squamous cell carcinoma (OTSCC), we examined its expression in OTSCC cell lines and we evaluated the effect of Nox4 knockdown on cell proliferation in vitro
A total of 161 patients with OTSCC who received surgical resection were retrospectively examined at Kaohsiung Chang Gung Memorial Hospital
Summary
Head and neck squamous cell carcinoma (HNSCC) is one of the leading cancers worldwide and there are an estimated 500,000 new cases being diagnosed annually [1]. Treatment of oral tongue squamous cell carcinoma (OTSCC) includes a single surgical resection, radiotherapy, chemotherapy, targeted therapy or a combination of these modalities. The current study was designed to evaluate the prognostic significance of Nox in patients with oral tongue squamous cell carcinoma (OTSCC) receiving surgical resection. Western blotting analysis indicated that Nox was highly expressed in these two OTSCC cell lines and knockdown of Nox was successful by transfecting with Nox shRNA These cell lines were treated with a Nox inhibitor (GKT-137831) and the results showed GKT-137831 could inhibit the proliferation of OTSCC tumor cells in a dose-dependent manner. Conclusion: Our study suggests that Nox plays an important role in disease progression of OTSCC and Nox overexpression is a poor prognostic factor for patients with OTSCC who received surgical resection
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
